Comparison of serum and liver hepatitis C virus quasispecies in HCV- related hepatocellular carcinoma

Journal of Hepatology

Volumn 29, Issue 6, 1998, Pages 887-892

  De Mitri, Maria Stella ^a   Mele, Loredana ^b   Chen, Chiu Hua ^b   Piccinini, Andrea ^b   Chianese, Raffaela ^b   D'Errico, Antonia ^b   Alberti, Alfredo ^b   Pisi, Emilio ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

Hepatitis C virus; Hepatocellular carcinoma; Hypervariable region; Quasispecies; Single strand conformation polymorphism

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERUM; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS GENOME;

EID: 0032403095     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80115-3     Document Type: Article

References (34)

1. 1. Di Bisceglie AM, Rustgi VK, Hoofnagle JM, Dusheiko JM, Lotze MT. Hepatocellular carcinoma. Ann Intern Med 1988; 108: 390-401.
2. 2. Kew MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984; 2: 136-46.
3. 3. Colombo M, Choo QL, Del Ninno, Dioguardi N, Kuo G, Donato MF, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; ii: 1006-8.
4. 4. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in Southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 873-5.
5. 5. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-9.
6. 6. Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol 1994; 19: 222-6.
7. 7. De Mitri MS, Baccarini P, Bonazzi C, Paterlini P, Pisi E. Potential molecular mechanisms of viral liver carcinogenesis. In: Gentilini P, Dianzani MU, editors. New Trends in Hepatology. Dordrecht: Kluwer Academic Publ.; 1996. p. 183-96.
8. 8. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381-8.
9. 9. Schirmacher P, Rogler CE, Dienes HP. Current pathogenetic and molecular concepts in viral carcinogenesis. Virchows Arch B Cell Pathol 1993; 63: 71-89.
10. 10. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345: 413-5.
11. 11. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989; 244: 359-62.
12. 12. Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, Ortin J, et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance: a review. Gene 1985; 40: 1-8.
13. 13. Martell M, Esteban JI, Quer J, Genescà J, Weiner A, Esteban R, et al. Hepatitis C (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225-9.
14. 14. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-83.
15. 15. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995; 22: 30-5.
16. 16. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994; 20: 1144-51.
17. 17. Naito M, Hayashi N, Moribe T, Hagiwara H, Mita E, Kanazawa Y, et al. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 1995; 22: 407-12.
18. 18. Shindo M, Arai K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology 1995; 22: 418-25.
19. 19. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C genomes. Hepatology 1994; 19: 1321-4.
20. 20. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-102.
21. 21. Knodell RG, Ishack KG, Black WC, Chen TS, Craig R, Kaplowits N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymtomatic chronic active hepatitis. Hepatology 1981; 5: 431-3.
22. 22. Edmonson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
23. 23. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8.
24. 24. Chomczynsky P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
25. 25. Paterlini P, Driss F, Pisi E, Nalpas B, Franco D, Berthelot P, et al. Persistence of hepatitis B and C viral genomes in primary liver cancers from HBsAg negative patients: a study of a low endemic area. Hepatology 1993; 17: 20-9.
26. 26. Gyllensten UB, Erlich HA. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA 1988; 85: 7652-6.
27. 27. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-9.
28. 28. Yap E-PH, McGee JO. Nonisotopic SSCP detection in PCR products by ethidium bromide staining. Trend Genet 1992; 8: 49.
29. 29. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol 1994; 75: 1361-9.
30. 30. Kurosaki M, Enomoto N, Sakamoto N, Tanaka Y, Tang L, Hoshino Y, et al. Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma tissues. J Hepatol 1995; 22: 527-35.
31. 31. Sakamoto N, Enomoto N, Kurosaki M, Asahina Y, Maekawa S, Koizumi K, et al. Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver. J Med Virol 1995; 46: 7-11.
32. 32. Cabot B, Esteban JI, Martell M, Genescà J, Vargas V, Esteban R, et al. Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions. J Virol 1997; 71: 1732-4.
33. 33. Saito S, Kato N, Hijikata M, Gunji T, Itabashi M, Kondo M, et al. Comparison of hypervariable regions (HVR1 and HVR2) in positive-and negative-stranded hepatitis C virus RNA in cancerous and non-cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatocellular carcinoma. Int J Cancer 1996; 67: 199-203.
34. 34. Weiner AJ, Geysen HM, Cristopherson C, Hall JE, Mason TJ, Saracco G, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468-72.